Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 14 citing Kanatani: Effects of pioglitazone on suppressor of cytokine signaling 3 expression. (0.17 sec) 

Adiponectin and its role in cardiovascular diseases


J Beltowski, A Jamroz-Wisniewska, S … - Cardiovascular &# 38; …, 2008 - ingentaconnect.com
Page 1. Cardiovascular & Haematological Disorders-Drug Targets, 2008, 8, 7-46 7 1871-529X/08
$55.00+.00 © 2008 Bentham Science Publishers Ltd. Adiponectin and its Role in Cardiovascular
Diseases Jerzy Be towski * , Anna Jamroz-Wi niewska and Sylwia Widomska ...
Cited by 11 - Related articles - BL Direct

How insulin receptor substrate proteins regulate the metabolic capacity of the liver- …

- bentham.org [PDF] 
L Fritsche, C Weigert, HU Haring, R … - Current medicinal …, 2008 - ingentaconnect.com
Department of Internal Medicine 4, Div. of Clinical Chemistry and Pathobiochemistry, Central
Laboratory, University Hospital Tue- bingen, D-72076 Tuebingen, Germany Abstract: The liver plays a
key role in glucose homeostasis, ...
Cited by 10 - Related articles - BL Direct - All 5 versions

Ginsenoside Re Reduces Insulin Resistance through Inhibition of c-Jun NH2- …

- endojournals.org
Z Zhang, X Li, W Lv, Y Yang, H Gao, J Yang, Y … - Molecular …, 2008 - Endocrine Soc
Ginsenoside Re (Re), a compound derived from Panax ginseng, shows an antidiabetic effect. However,
the molecular basis of its action remains unknown. We investigated insulin signaling and the
antiinflammatory effect by Re in ...
Cited by 9 - Related articles - BL Direct - All 4 versions

Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic …


N Rafiq, ZM Younossi - Expert Review of Gastroenterology and …, 2008 - ingentaconnect.com
Nonalcoholic fatty liver disease (NAFLD) has become one of the most prevalent liver diseases in the
Western world. NAFLD represents a wide spectrum of histologic subgroups, with nonalcoholic
steatohepatitis as the most ...
Cited by 3 - Related articles - BL Direct - All 4 versions

噻唑烷二酮类药物的研究进展


邱能, 罗有福 - 药学进展, 2007 - cqvip.com
首页; 期刊导航; 知识社区; 学者空间; 学术机构; 专题导读; 充值中心; 论文翻译. 登录
注册 帮助. 维普资讯 中文期刊·专业文章. 维普专业检索Google学术. 药学 >> 药学进展 >>
2007年31卷10期 >> 摘要. 噻唑烷二酮类药物的研究进展. 评论推荐. ...
Cited by 2 - Related articles - All 4 versions

Functional genomic analysis of frataxin deficiency reveals tissue-specific …

- nih.gov
G Coppola, D Marmolino, D Lu, Q Wang, M … - Human Molecular …, 2009 - Oxford Univ Press
Friedreich's ataxia (FRDA), the most common inherited ataxia, is characterized by focal
neurodegeneration, diabetes mellitus and life-threatening cardiomyopathy. Frataxin, which is
significantly reduced in patients ...
Cited by 1 - Related articles - All 4 versions

Omega-3 fatty acids exacerbate DSS-induced colitis through decreased …


H Matsunaga, R Hokari, C Kurihara, Y … - Inflammatory Bowel …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ...
Cited by 1 - Related articles - All 2 versions

A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes


M Dorkhan, A Frid - Vascular Health and Risk Management, 2007 - pubmedcentral.nih.gov
Type 2 diabetes (T2D) is a progressive disorder with a consistent and steady increase in
glycosylated hemoglobin (HbA 1 c) over time associated with enhanced risk of micro- and
macrovascular complications and a ...
Cited by 1 - Related articles - BL Direct - All 7 versions

Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease …


K Nagao, N Inoue, M Inafuku, B Shirouchi, T … - The Journal of Nutritional …, 2009 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common liver disease in
industrialized countries. Thus, the discovery of food components that would ameliorate NAFLD is of
interest. Various mushrooms have ...
Related articles - All 2 versions

Hepatitis C, insulin resistance, and steatosis

- current-reports.com [PDF] 
DM Torres, SA Harrison - Current Hepatitis Reports, 2007 - Springer
Introduction The current prevalence of hepatitis C in the United States is estimated to be roughly
1.6%, with 1.3% having chronic hepatitis C (CHC) infection. This equates to 3.2 million people in
the United States alone [1]. The ...
Related articles - All 3 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google